Primary Aldosteronism: Screening and Treatment Essentials

March 2026

You’re in a key spot to help manage patients with primary aldosteronism (PA)...when adrenal glands make too much aldosterone.

This leads to problems, such as sodium retention, low potassium, and hypertension, which can increase cardiovascular and kidney disease risk.

Recent Endocrine Society guidelines suggest screening ALL patients with hypertension for PA.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote